what is tradjenta used for
Tradjentaâs U.S. sales topped $25 million in the first quarter of 2012 and $33 million in the second quarter. Although Tradjenta does control blood sugar, it comes with the risk of serious side effects, including pancreatitis. The FDA is investigating reports of additional risks, including pancreatic cancer.